FATE vs TFC · rev $13.6M vs rev $24.54B
Fate Therapeutics Inc (FATE) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
TFC (TFC) common stock.
Latest reported FATE revenue for 2024-12-31 was $13.6M. Net income was -$186.3M. Revenue was down 78.5% from 2023-12-31 to 2024-12-31. FATE currently screens at market cap $331.0M.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
FATE currently screens at market cap $331.0M. TFC currently screens at market cap $0.
Not investment advice. Open the FATE and TFC stock pages for the full models.
Not investment advice.